Posts in tag

NSAIDs


Painkillers like ibuprofen can increase the risk of heart disease and should be restricted Michael Stokes, University of Adelaide and Peter Psaltis, South Australian Health & Medical Research Institute Medications …

“Such was the pro-pharmacy headline greeting me this morning from last night’s Australian Doctor, reporting on a Danish study in European Heart Journal.   NSAIDs should not be available for open …

We take a look back at the week in pharmacy With the biggest event on the conference calendar, APP, finished over the weekend, it’s now time for Health Minister Greg …

Australians should not be alarmed by the results of a Danish study which indicate NSAIDs should be pharmacy-only, says ASMI The Australian Self Medication Industry said today that it acknowledges …

They increase risk of cardiac arrest and should only be available in pharmacies and in low doses, researchers say NSAIDs are among the most commonly used drugs worldwide, but their …

Debbie Rigby takes a look at the latest in research news Acid suppression medications and bacterial gastroenteritis A Scottish cohort study has use of proton pump inhibitors (PPIs) and H2 …

There are effective approaches to managing back pain, but they’re not as simple as taking a pill, say researchers from The George Institute Gustavo Machado, Research fellow, George Institute for Global …

NSAIDs such as ibuprofen and diclofenac remain a suitable choice for relief of acute pain for most people, says ASMI ASMI was responding to reporting of an Australian study at …

There is an urgent need to develop clinically effective and safe drug therapies to treat back pain, say Australian researchers A systematic review and meta-analysis conducted by The George Institute …

Debbie Rigby takes a look at the latest in research news Improving the Management of COPD in Women Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that represents …

The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties …

Celecoxib is no more likely to cause cardiovascular events than ibuprofen or naproxen, the PRECISION trial has found Before this trial, the cardiovascular safety of celecoxib as compared with nonselective …